Search Within

Genitourinary Oncology Service

  1. "Peter Scardino"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (22)
  3. Book Section (2)
Groups
  1. Department of Medicine (68)
  2. Molecular Pharmacology and Chemistry Program Faculty (68)
  3. Sloan Kettering Institute Faculty (68)
  4. Solid Tumor Oncology Division (68)
  5. Surgery (68)
  6. Urology (68)

More Groups

People
  1. Peter Scardino (68)
  2. Howard Scher (54)
  3. James Eastham (28)
  4. Victor Reuter (24)
  5. Hedvig Hricak (14)
  6. Fernando Bianco (12)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2018 (2)
  4. 2017 (3)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Clinical Cancer Research (5)
  3. Radiology (5)
  4. Journal of Urology (4)
  5. BJU International (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (10)
  3. Elsevier Science, Inc. (9)
  4. Nature Publishing Group (5)
  5. Radiological Society of North America, Inc. (5)
  6. Wiley Blackwell (4)

More Publishers

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance
    Journal Article

    Jibara, G. A.; Perera, M.; Vertosick, E. A.; Sjoberg, D. D.; Vickers, A.; Scardino, P. T.; Eastham, J. A.; Laudone, V. P.; Touijer, K.; Lin, X.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing
    Meeting Abstract

    Truong, H.; Breen, K.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Benfante, N.; Ehdaie, B.; Touijer, K. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PSA-targeted alpha-, beta-, and positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
    Journal Article

    Veach, D. R.; Storey, C. M.; Lückerath, K.; Braun, K.; von Bodman, C.; Lamminmäki, U.; Kalidindi, T.; Strand, S. E.; Strand, J.; Altai, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
    Journal Article

    Hieronymus, H.; Murali, R.; Tin, A.; Yadav, K.; Abida, W.; Moller, H.; Berney, D.; Scher, H.; Carver, B.; Scardino, P.; more...
    eLife (2018)

    Fulltext@MSK | Save
  • Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
    Journal Article

    McDevitt, M. R.; Thorek, D. L. J.; Hashimoto, T.; Gondo, T.; Veach, D. R.; Sharma, S. K.; Kalidindi, T. M.; Abou, D. S.; Watson, P. A.; Beattie, B. J.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Periprostatic adipose inflammation is associated with high-grade prostate cancer
    Journal Article

    Gucalp, A.; Iyengar, N. M.; Zhou, X. K.; Giri, D. D.; Falcone, D. J.; Wang, H.; Williams, S.; Krasne, M. D.; Yaghnam, I.; Kunzel, B.; more...
    Prostate Cancer and Prostatic Diseases (2017)

    Fulltext@MSK | Save
  • A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer
    Journal Article

    O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Touijer, K. A.; Morris, M. J.; Danila, D. C.; Laudone, V. P.; Bochner, B. H.; Sheinfeld, J.; Dayan, E. S.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy
    Journal Article

    Robertson, N. L.; Sala, E.; Benz, M.; Landa, J.; Scardino, P.; Scher, H. I.; Hricak, H.; Vargas, H. A.
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy
    Meeting Abstract

    Miller, K.; Mulders, P.; Freedland, S. J.; Scher, H.; Shore, N.; Park, E.; Krivoshik, A.; Phung, D.; Modelska, K.; Scardino, P.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
    Journal Article

    Thorek, D. L. J.; Watson, P. A.; Lee, S. G.; Ku, A. T.; Bournazos, S.; Braun, K.; Kim, K.; Sjostrom, K.; Doran, M. G.; Lamminmaki, U.; more...
    Science Translational Medicine (2016)

    Fulltext@MSK | Save